These novel therapies , Retatrutide, represent a significant advancement in treating type 2 diabetes and conceivably other ailments . These drugs are categorized as GLP-1 receptor agonists , indicating these substances to emulate the natural GLP-1 hormone , enhancing metabolic release and suppressing hunger . Although Tirzepatide each functions rel